We report the draft genome sequence of Acinetobacter baumannii strain MAR002, a biofilm-hyperproducing clinical strain isolated during the study CP/09/0033 (GEIH/REIPI-Ab2010, Spain). The genome of A. baumannii MAR002 has an approximate length of 3,717,929 bp and 3,300 protein-coding sequences, with a C؉G content of 39.09%. 
cinetobacter baumannii is a nonfermentative Gram-negative coccobacillus. Although this species is a normal inhabitant of the human skin flora, intestinal tract, and respiratory system, it has been shown to cause nosocomial infections, particularly in immunocompromised individuals (1, 2) . Biofilm formation is frequent in clinical strains of A. baumannii and is an important requirement for chronic colonization of human tissues and persistence in hospital surfaces and medical devices (3, 4) . In this study, we report a draft genome sequence of the biofilm-hyperproducing A. baumannii strain MAR002, isolated from a wound sample collected from a patient. Genomic DNA was isolated using the Wizard genomic DNA purification kit (Promega) following the manufacturer's protocols. Genome sequencing was performed using the GS Junior sequencer (454 Life Sequencing Inc., Branford, CT). A whole-genome shotgun fragment library was constructed using the rapid library preparation kit from 500 ng of genomic DNA. The GS Junior Titanium emulsion PCR (emPCR) kit (Lib-L) was used for the amplification of the shotgun library. The GS Junior Titanium sequencing kit combined with the GS Junior Titanium PicoTiterPlate kit was used to determine the nucleotide sequence of the amplified DNA library. Standard 454 pyrosequencing protocols were followed. Reads were assembled into contigs using the 454 gsAssembler software program with default parameters. Contigs were reordered onto the A. baumannii ATCC 17978 (NCBI reference sequence no. NC_009085.1), A. baumannii AB0057 (NC_011586.1), A. baumannii AYE (NC_010410.1) and A. baumannii AbH12O-A2 (CP009534.1) reference genomes using the contig ordering tool of the Java-based graphical-interface program Mauve (version 2.3.1) (5, 6). Specific nucleotides were designed for PCR procedures followed by Sanger sequencing in order to close gaps. Genome annotation was performed using the NCBI Prokaryotic Genomes Automatic Annotation Pipeline. PHAST (Phage Search Tool) was used to identify prophage sequences within the A. baumannii MAR002 genome (7) . A total of 163,265 reads (77,182,857 bp) were generated, with an average length of 541.12 bp, and 99.23% of the reads were assembled. A total of 119 contigs were obtained, 111 of which were large contigs (Ͼ500 bp) with lengths between 574 bp and 170,823 bp. The average size of these large contigs was 32,989 bp, and the N 50 was 61,192 bp. After the contig assembly two scaffolds were obtained, scaffold 01 with a length of 2,960,191 bp and a 38.92% GϩC content and scaffold 02 with a length of 757,739 bp and a 39.70% GϩC content. The estimated complete genome size was 3.72 Mb, with a GϩC content of 39.09%. A total of 3,300 protein-coding sequences, 75 pseudogenes, 69 tRNAs, and 6 rRNA clusters were predicted. Using the RAST program, A. baumannii AYE, A. baumannii ACICU, and A. baumannii AB900 were identified as the closest neighbors, with scores of 535, 515, and 492, respectively (8, 9) . PHAST analysis revealed a putative intact phage integrated in the genome similar to Acinetobacter phage Bphi-B1251 (NC_019541.1), with a length of 54.1 kb, 62 proteincoding sequences, and a GϩC content of 36.99%.
Nucleotide sequence accession numbers. This wholegenome shotgun project has been deposited at GenBank into two scaffolds under the accession numbers JRHB01000001 and JRHB01000002.
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